P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY.

• Pierre Peterlin,
• Alice Garnier,
• Amandine Le Bourgeois,
• Thierry Guillaume,
• Maxime Jullien,
• Lucie Planche,
• Joelle Gaschet,
• Patrice Chevallier

Affiliations

Pierre Peterlin

1 Nantes University Hospital, clinical hematology, nantes, France

Alice Garnier

2 Nantes University Hospital, clinical hematology, nantes, France

Amandine Le Bourgeois

2 Nantes University Hospital, clinical hematology, nantes, France

Thierry Guillaume

2 Nantes University Hospital, clinical hematology, nantes, France

Maxime Jullien

2 Nantes University Hospital, clinical hematology, nantes, France

Lucie Planche

3 Departmental Hospital Centre, Clinical Research Centre, La roche sur Yon, France

Joelle Gaschet

4 CRCI2NA - Equipe 2 UMR INSERM 1307 CNRS 6075 - Nantes Université -Université d’Angers, CRCI2NA - Equipe 2 UMR INSERM 1307 CNRS 6075 - Nantes Université -Université d’Angers, nantes, France

Patrice Chevallier

2 Nantes University Hospital, clinical hematology, nantes, France